Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

TDP2 antibody

This Mouse Monoclonal antibody specifically detects TDP2 in WB and FACS. It exhibits reactivity toward Human.
Catalog No. ABIN2704362

Quick Overview for TDP2 antibody (ABIN2704362)

Target

See all TDP2 Antibodies
TDP2 (tyrosyl-DNA phosphodiesterase 2 (TDP2))

Reactivity

  • 49
  • 31
  • 9
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Human

Host

  • 48
  • 16
Mouse

Clonality

  • 50
  • 14
Monoclonal

Conjugate

  • 28
  • 4
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This TDP2 antibody is un-conjugated

Application

  • 48
  • 27
  • 26
  • 22
  • 20
  • 13
  • 13
  • 11
  • 8
  • 6
  • 3
  • 2
  • 1
  • 1
Western Blotting (WB), Flow Cytometry (FACS)

Grade

GMP Grade

Clone

42c
  • Purpose

    Anti-EAPII Unconjugated Antibody

    Characteristics

    EAPII (also called TTRAP, TDP2) originally was identified as an interacting partner of oncogene ETS1, a founding member of ets transcription factor, and the cytoplasmic domain of CD40, a member of the tumor necrosis factor (TNF) receptor family. EAPII significantly represses ETS1 transcriptional activity and the synergistic transactivation by ETS1 and AP-1 or by ETS1 and NFκB. EAPII/TTRAP also inhibits the transcriptional activation of NFB induced by CD40 or phorbol 12-myristate 13-acetate (PMA). Recently this protein was also proven to be the first 5'- tyrosyl-DNA phosphodiesterase. EAPII has been demonstrated to have promiscuous protein associations, broad responsiveness to various extracellular signals, and pleiotropic functions in the development of human diseases including cancer and neurodegenerative disease. Emerging data suggest that EAPII is a multi-functional protein: it repairs enzyme (topoisomerase)-mediated DNA damage by removing phosphotyrosine from DNA adducts, involves in multiple signal transduction pathways such as TNF-TNFR, TGFβ and MAPK, and responsive to immune defense including inflammatory response, viral infection and DNA toxins (chemo or radiation therapy). EAPII predominantly localizes to the nucleus, but based on pathological conditions it also localizes in both cytoplasm and nucleus.

    Purification

    Purified

    Purity

    >95 %

    Immunogen

    Recombinant full length protein

    Isotype

    IgG2b, kappa
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    0.5 mg/mL

    Buffer

    PBS pH 7.2, 0.1 % (w/v) BSA, 0.09 % (w/v) sodium azide

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C
  • Target

    TDP2 (tyrosyl-DNA phosphodiesterase 2 (TDP2))

    Alternative Name

    EAPII

    NCBI Accession

    NM_016614

    UniProt

    O95551
You are here:
Chat with us!